Equities

SBC Medical Group Holdings Inc

SBC:NMQ

SBC Medical Group Holdings Inc

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)6.50
  • Today's Change0.00 / 0.00%
  • Shares traded40.24k
  • 1 Year change-38.97%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 17:06 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year SBC Medical Group Holdings Inc grew revenues 11.13% from 174.16m to 193.54m. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 523.44% net income growth from 6.32m to 39.37m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, SBC Medical Group Holdings Inc increased its cash reserves by 99.12%, or 51.28m. The company earned 50.67m from its operations for a Cash Flow Margin of 26.18%. In addition the company generated 1.79m and 6.14m cash from investing and financing, respectively.
Cash flow per share--
Price/Cash flow per share--
Book value per share1.99
Tangible book value per share1.80
More ▼

Balance sheet in USDView more

SBC Medical Group Holdings Inc has a Debt to Total Capital ratio of 9.94%.
Current ratio2.79
Quick ratio2.76
Total debt/total equity0.1107
Total debt/total capital0.0994
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 523.44%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.